Biophysical aspects of Auger processes

Acta Oncologica

Volumn 35, Issue 7, 1996, Pages 789-796

  Hofer, Kurt G ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOMES; DNA; ELECTRON EMISSION; ELECTRONS; RADIATION EFFECTS; RADIOISOTOPES; TOXICITY;

AUGER EFFECT; ELECTRON CAPTURE; ELECTRON IRRADIATION;

ATOMIC PHYSICS;

ANIMAL CELL; AUGER ELECTRON SPECTROSCOPY; BIOPHYSICS; CELL DEATH; CHROMOSOME ABERRATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA STRAND BREAKAGE; MALIGNANT TRANSFORMATION; MUTATION; PRIORITY JOURNAL; RADIOISOTOPE DECAY;

BIOPHYSICS; DNA; DNA DAMAGE; IODINE RADIOISOTOPES; LINEAR ENERGY TRANSFER; NEOPLASMS; RADIATION DOSAGE; RADIOISOTOPES; RADIONUCLIDE GENERATORS;

EID: 0030446508     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609104028     Document Type: Article

References (81)

1. Adelstein SJ. Biophysical aspects of Auger processes: a review of the literature 1987-1991. In: Howell RW, Narra VR, Sastry KSR, Rao DV, eds. Biophysical aspects of Auger processes. Woodburry, NY: American Institute of Physics, Inc., 1992: 1-13.
2. Auger P. Sur les rayons β secondaires produit dans un gaz des rayons X. Comp Rend 1925; 180: 65-8.
3. 125I-iododeoxyuridine. J Natl Cancer Inst 1969; 43: 763-73.
4. Ertl HH, Feinendegen LE, Heiniger HJ. Iodine-125, a tracer in cell biology: physical properties and biological aspects. Phys Med Biol 1970; 15: 447-56.
5. Feinendegen LE, Ertl HH, Bond VP. Biological toxicity associated with the Auger effect. In: Ebert H, ed. Proceedings of the Symposium on Biological Aspects of Radiation Quality. Vienna: IAEA, 1971: 419-30.
6. Hofer KG, Hughes WL. Radiotoxicity of intranuclear tritium, iodine-125, and iodine-131. Radiat Res 1971; 47: 94-109.
7. Smith EM, Harris CC, Rohrer RH. Calculation of local energy deposition due to electron capture and internal conversion. J Nucl Med 1966; 7: 23-31.
8. Gillespie FC, Orr JS, Greig WR. Microscopic dose distribution from I-125 in the toxic thyroid gland and its relation to therapy. Br J Radiol 1970; 43: 40-7.
9. 125I. Radiat Res 1981; 87: 10-23.
10. Kassis AI, Adelstein SJ, Haydock C, Sastry KSR. Radiotoxicity of Se-75 and S-35: theory and application to a cellular model. Radiat Res 1980; 84: 407-25.
11. Kassis AI, Adelstein SJ, Haydock C, Sastry KSR, McElvany KD, Welch MJ. Lethality of Auger electrons from the decay of bromide-77 in the DNA of mammalian cells. Radiat Res 1982; 90: 363-73.
12. Rao DV, Govelitz GF, Sastry KSR. Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med 1983; 34: 145-53.
13. Rao DV, Sastry KSR, Govelitz GF, Grimmond HE, Hill HZ. In vivo effects of iron-55 and iron-59 on mouse testes: biophysical dosimetry of Auger electrons. J Nucl Med 1985; 26: 1456-65.
14. Kassis AI, Sastry KSR, Adelstein SJ. Intracellular distribution and radiotoxicity of chromium-51 in mammalian cells: Auger electron dosimetry. J Nucl Med 1985; 26: 59-67.
15. Rao DV, Sastry KSR, Grimmond HE, et al. Cytotoxicity of some indium radiopharmaceuticals in mouse testes. J Nucl Med 1988; 29: 375-84.
16. Makrogiorgos GM, Kassis AI, Baranowska-Kortylewicz J, et al. Radiotoxicity of 5-[I-125]iodo-2′-deoxyuridine in V79 cells: a comparison with 5-[I-123]iodo-2′-deoxyuridine. Radiat Res 1989; 118: 532-44.
17. Howell RW. Radiation spectra for Auger-electron emitting radionuclides: report No 2 of AAPM Nuclear Medicine Task Group No 6. Med Phys 1992; 19: 71-83.
18. Humm JL, Howell RW, Rao DV. Dosimetry of Auger-electron emitting radionuclides: report No 3 of AAPM Nuclear Medicine Task Group No 6. Med Phys 1994; 21: 1901-15.
19. Weber DA, Eckerman KF, Dillman LT, Ryman JC. New York: Society of Nuclear Medicine: 1989 MIRD: Radionuclide Data and Decay Schemes.
20. Pomplun E, Booz J, Charlton DE. A Monte Carlo simulation of Auger cascades. Radiat Res 1987; 111: 533-52.
21. 4. Int J Radiat Biol 1974; 25: 21-30.
22. + and recA strains of Escherichia coli. Int J Radiat Biol 1976; 29: 37-50.
23. 125I incorporated into mammalian DNA. Proc Natl Acad Sci USA 1974; 71: 4836-8.
24. Martin RF, Haseltine WA. Range of radiochemical damage to DNA with decay of iodine-125. Science 1981; 213: 896-8.
25. 125I decay. In: Howell RW, Narra VR, Sastry KSR, Rao DV, eds. Biophysical aspects of Auger processes. Woodburry, NY: American Institute of Physics, Inc., 1992: 210-26.
26. Pomplun E. A new DNA target model for track structure calculations and its first application to I-125 Auger electrons. Int J Radiat Biol 1991; 59: 625-42.
27. Paretzke HG. Radiation track structure theory. In: Freeman GR, ed. Kinetics of inhomogeneous processes. New York: Wiley, 1987: 89-170.
28. 125I. In: Howell RW, Narra VR, Sastry KSR, Rao DV, eds. Biophysical aspects of Auger processes. Woodburry, NY: American Institute of Physics, Inc., 1992: 137-52.
29. 125I on a nucleosome. Int J Radiat Biol 1994; 66: 447-51.
30. Pomplun E, Terrissol M. Low-energy electrons inside active DNA models: a tool to elucidate the radiation action mechanisms. Radiat Environ Biophys 1994; 33: 279-92.
31. 125I. Int J Radiat Biol 1988; 53: 353-65.
32. Makrigiorgos GM, Berman RM, Baranowska-Kortylewicz J, et al. DNA damage produced in V79 cells by DNA-incorporated iodine-123: a comparison with iodine-125. Radiat Res 1992; 129: 309-14.
33. Sahu SK, Kassis AI, Makrigiorgos GM, Baranowska-Kortylewicz J, Adelstein SJ. The effect of indium-111 decay on pBR322 DNA. Radiat Res 1995; 141: 193-8.
34. 125I labeled oligonucleotides. Nucleic Acid Res 1994; 22: 4979-82.
35. 125I]iodo-2′-deoxyuridine incorporated into DNA of mammalian cells, and their RBEs. Radiat Res 1981; 88: 456-65.
36. Little JB, LeMotte PK, Liber HL. Quantitative studies of cytotoxicity, mutagenesis and oncologic transformation by radioisotopes incorporated into DNA. In: Harris CC, Auhup HN, eds. Human carcinogenesis. New York: Academic Press, 1983: 545-59.
37. 3H-TdR. Radiat Res 1976; 67: 322-43.
38. 125I incorporated into DNA of Chinese hamster cells. Mutat Res 1985; 149: 257-63.
39. Warters RL, Hofer KG. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site for radiation-induced mitotic delay. Radiat Res 1977; 69: 348-58.
40. Schneiderman MH, Hofer KG. The target for radiation-induced division delay. Radiat Res 1980; 84: 462-76.
41. Hofer KG. Radiation biology and potential therapeutic applications of radionuclides. Bull Cancer 1980; 67: 343-53.
42. 3H: nuclear versus cytoplasmic radiation effects in murine L1210 leukemia. Int J Radiat Biol 1975; 28: 225-41.
43. Warters RL, Hofer KG, Harris CR, Smith JM. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary target of radiation damage. Curr Top Radiat Res Q 1977; 12: 389-407.
44. 125I decay. Int J Radiat Biol 1986; 49: 601-10.
45. Hofer KG, Keough G, Smith JM. Biological toxicity of Auger emitters: molecular fragmentation vs. electron irradiation. Curr Top Radiat Res Q 1977; 12: 335-54.
46. Makrigiorgos GM, Adelstein SJ, Kassis AI. Limitation of conventional internal dosimetry at the cellular level. J Nucl Med 1989; 30: 1856-64.
47. Goddu SM, Howell RW, Rao DV. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med 1994; 35: 305-16.
48. Faraggi M, Gardin I, deLabriolle-Vaylet C, Moretti JL, Bok BD. The influence of tracer localization on the electron dose rate delivered to the cell nucleus. J Nucl Med 1994; 35: 113-9.
49. Jonkhoff AR, vDieren EB, Huijgens PC, et al. Biological effectiveness of 67-gallium in HL60 cells compared with external low dose rate gamma irradiation: effects on proliferation. G2 arrest, and clonogenic capacity. Int J Radiat Oncol Biol Phys 1994; 30: 117-24.
50. 125I-labeled thyroid hormone in hormone-responsive cells. Int J Radiat Biol 1992; 61: 639-53.
51. Narra VR, Howell RW, Harapanhalli RS, Sastry KSR, Rao DV. Radiotoxicity of some iodine-123, iodine-125, and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design. J Nucl Med 1992; 33: 2196-201.
52. Narra VR, Howell RW, Sastry KSR, Rao DV. Auger electron emitters as tools for elucidating the location of primary radiosensitive targets. Radiat Prot Dosim 1994; 52: 229-32.
53. Howell RW, Rao DV, Hou DY, Narra VR, Sastry KSR. The question of relative biological effectiveness and quality factor for Auger emitters incorporated into proliferating mammalian cells. Radiat Res 1991; 128: 282-92.
54. 123I: the use of the Auger effect as a biologic probe at the nanometre level. Radiat Prot Dosim 1990; 31: 333-8.
55. Kassis AI, Fayad F, Kinsey BM, Sastry KSR, Adelstein SJ. Radiotoxicity of an I-125-labeled DNA intercalator in mammalian cells. Radiat Res 1989; 118: 283-94.
56. McLean RN, Wilkinson D. The radiation dose to cells in vitro from intracellular indium-Ill. Biochem Cell Biol 1989; 67: 661-5.
57. Rao DV, Narra VR, Howell RW, Lanka VK, Sastry KSR. Induction of spermhead abnormalities by incorporated radionuclides: dependence on subcellular distribution, type of radiation, dose rate and presence of radioprotectors. Radiat Res 1991; 125: 89-97.
58. Narra VR, Harapanhalli RS, Howell RW, Sastry KSR, Rao DV. Vitamins as radioprotectors in vivo: I. Protection by vitamin C against internal radionuclides in mouse testes: implications to the mechanism of the Auger effect. Radiat Res 1994; 137: 394-9.
59. Narra VR, Harapanhalli RS, Goddu SM, Howell RW, Rao DV. Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothioronium bromide hydrobromide (AET). J Nucl Med 1995; 36: 259-66.
60. Harapanhalli RS, Narra VR, Yaghmai V, et al. Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides. Radiat Res 1994; 139: 115-22.
61. 125I decay. Radiat Res 1992; 130: 121-4.
62. Hofer KG, VanLoon N, Schneiderman MH, Charlton DE. High LET and low LET cytocidal effects of DNA-associated iodine-125. In: Howell RW, Narra VR, Sastry KSR, Rao DV, eds. Biophysical aspects of Auger processes. Woodburry, NY: American Institute of Physics, Inc., 1992: 227-48.
63. 125I decays in DNA: effect of cysteamine on micronucleus formation and cell death. Radiat Res 1995; 141: 183-92.
64. Howell RW, Rao DV, Sastry KSR. Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors. Med Phys 1989; 16: 66-74.
65. Strand SE, Jönsson BA, Ljungberg M, Tennvall J. Radioimmunotherapy dosimetry - a review. Acta Oncol 1993; 32: 807-17.
66. Humm JL, Macklis RM, Lu XQ, et al. The spatial accuracy of cellular dose estimates obtained from 3D reconstructed tissue autoradiographs. Phys Med Biol 1995; 40: 163-80.
67. Schneiderman MH, Schneidermann GS. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies. J Nucl Med 1996; 37 (Suppl.): 65-95.
68. Klecker RW Jr, Jenkins JF, Kinsella TJ, Fine RL, Strong JM, Collins JM. Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin Pharmacol Ther 1985; 38: 45-51.
69. 125I-iododeoxyuridine and azauridine. Cancer Res 1963; 23: 1246-59.
70. 125I]iodo-2′-deoxyuridine in cancer. In: Howell RW, Narra VR, Sastry KSR, Rao DV, eds. Biophysical aspects of Auger processes. Woodburry, NY: American Institute of Physics, Inc., 1992: 372-95.
71. 125I]iodo-2′-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 1990; 50: 5199-203.
72. Mariani G, Cei A, Collechi P, et al. Tumor targeting in vivo and metabolic fate of 5-[iodo-125]-iodo-2′-deoxyuridine following intratumoral injection in patients with colorectal cancer. J Nucl Med 1993; 34: 1175-83.
73. 125I]iodo-2′-deoxyuridine in patients with breast cancer. In: Höfer R, Bergmann H, Sinzinger H, eds. Radioactive isotopes in clinical medicine and research. Stuttgart - New York: Schattauer, 1993: 188-93.
74. Wheldon TE. Targeting radiation to tumours. Int J Radiat Biol 1994; 65: 109-15.
75. Bloomer WD, McLaughlin WH, Weichselbaum RR, Hanson RN, Adelstein SJ, Seitz DE. The role of subcellular localization in assessing the cytotoxicity of iodine-125 labeled iododeoxyuridine, iodotamoxifen and iodoantipyrine. J Radioanal Chem 1981; 65: 209-21.
76. 125I]iodo-estradiol in cultured MCF-7 human breast cancer cells. J Natl Cancer Inst 1989; 81: 437-40.
77. DeSombre ER, Shafi B, Hanson RN, Kiuvanen PC, Hughes A. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. Cancer Res 1992; 52: 5752-8.
78. Ozanne BW, Richards CS, Hendler FJ, Burns D, Gustersen B. Over-expression of the EGF receptor is a hall-mark of squamous cell carcinomas. J Pathol 1986; 149: 9-14.
79. Howell RW, Kassis AI, Adelstein SJ, et al. Radiotoxicity of platinum-195m-labeled trans-platmum (II) in mammalian cells. Radiat Res 1994; 140: 55-62.
80. Helene C. The anti-gene strategy: control of gene expression by triplex-forming oligonucleotides. Anti-Cancer Drug Design 1991; 6: 569-84.
81. Feinendegen LE. Biological damage from the Auger effect, possible benefits. Radiat Environ Biophys 1975; 12: 85-99.